apotransferrin

Biologicalexperimental

Transferrins are glycoproteins found in vertebrates which bind and consequently mediate the transport of iron (Fe) through blood plasma. They are produced in the liver and contain binding sites for two Fe3+ ions. Human transferrin is encoded by the TF gene and produced as a 76 kDa glycoprotein. — Wikipedia

Clinical trial activity

4 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0

Earliest trial started Dec 1, 2010 (NCT01797055)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • apotransferrin
  • human apotransferrin

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03993613Phase 2Mar 21, 2019Sanquin, University of Amsterdam
NCT02251041Phase 2Sep 1, 2014Katholieke Universiteit Leuven
NCT01886443Phase 1Aug 1, 2013Katholieke Universiteit Leuven
NCT01797055Phase 2/Phase 3 (Phase 3)Dec 1, 2010Azienda Ospedaliera San Gerardo di Monza, Sanquin, Universidad Autonoma de Barcelona
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Katholieke Universiteit LeuvenAcademic/Hospital2222013
SanquinAcademic/Hospital2222010
Azienda Ospedaliera San Gerardo di MonzaAcademic/Hospital1012010
Universidad Autonoma de BarcelonaAcademic/Hospital1012010
University of AmsterdamAcademic/Hospital1012019
5 organizations
Page 1 / 1